RE: RNS Ph3 Update20 Mar 2026 19:00
“remains on schedule to report top-line results in Spring 2026 in line with prior guidance.“
I think Spring months fall within March and May inclusive .
I take any of those , do not get hung up on this .
I would maybe expect a delay for a trial if this size , it is the nature of trials approval process , so not a big deal for me either way. but if on track , then that’s a massive thumbs up to achieve it .
However my eyes are on the bigger picture here, Approval will open Steriwave to a massive market globally , all being well of course